Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Liabilities and Shareholders Equity (2021 - 2025)

Rxo's Liabilities and Shareholders Equity history spans 5 years, with the latest figure at $3.3 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 4.01% year-over-year to $3.3 billion; the TTM value through Dec 2025 reached $13.0 billion, up 24.62%, while the annual FY2025 figure was $3.3 billion, 4.01% down from the prior year.
  • Liabilities and Shareholders Equity reached $3.3 billion in Q4 2025 per RXO's latest filing, up from $3.2 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.4 billion in Q4 2024 to a low of $1.8 billion in Q1 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $2.5 billion, with a median of $2.1 billion recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: dropped 13.01% in 2023, then skyrocketed 87.07% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.1 billion in 2021, then fell by 1.79% to $2.0 billion in 2022, then fell by 10.14% to $1.8 billion in 2023, then surged by 87.07% to $3.4 billion in 2024, then fell by 4.01% to $3.3 billion in 2025.
  • Per Business Quant, the three most recent readings for RXO's Liabilities and Shareholders Equity are $3.3 billion (Q4 2025), $3.2 billion (Q3 2025), and $3.2 billion (Q2 2025).